EFFECT OF DENOSUMAB ON BONE MINERAL DENSITIES IN POSTMENOPAUSAL WOMEN IN KKH

被引:0
|
作者
Chua, M. T. [1 ]
Ang, S. B. [2 ]
机构
[1] KKH, Div Nursing, Singapore, Singapore
[2] KKH, Family Med Serv, Singapore, Singapore
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P230
引用
收藏
页码:S775 / S775
页数:1
相关论文
共 50 条
  • [1] Denosumab in postmenopausal women with low bone mineral density
    McClung, MR
    Lewiecki, EM
    Cohen, SB
    Bolognese, MA
    Woodson, GC
    Moffett, AH
    Peacock, M
    Miller, PD
    Lederman, SN
    Chesnut, CH
    Lain, D
    Kivitz, AJ
    Holloway, DL
    Zhang, C
    Peterson, MC
    Bekker, PJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (08): : 821 - 831
  • [2] Denosumab in postmenopausal women with low bone mineral density
    Schwartzman, Julie
    Yazici, Yusuf
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (22): : 2390 - 2390
  • [3] Denosumab in postmenopausal women with low bone mineral density
    Charles L. Loprinzi
    Current Oncology Reports, 2006, 8 (4) : 267 - 268
  • [4] Effects of denosumab on bone mineral density and bone turnover in postmenopausal women
    Bone, Henry G.
    Bolognese, Michael A.
    Yuen, Chui Kin
    Kendler, David L.
    Wang, Huei
    Liu, Yu
    Martin, Javier San
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (06): : 2149 - 2157
  • [5] Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women
    Wensel, Terri M.
    Iranikhah, Maryam M.
    Wilborn, Teresa W.
    PHARMACOTHERAPY, 2011, 31 (05): : 510 - 523
  • [6] Effect of Denosumab on Bone Mineral Density and Markers of Bone Turnover among Postmenopausal Women with Osteoporosis
    Sanchez, A.
    Brun, L. R.
    Salerni, H.
    Costanzo, P. R.
    Gonzalez, D.
    Bagur, A.
    Oliveri, B.
    Zanchetta, M. B.
    Farias, V.
    Maffei, L.
    Premrou, V.
    Mansur, J. L.
    Larroude, M. S.
    Sarli, M. A.
    Rey, P.
    Ulla, M. R.
    Pavlove, M. M.
    Karlsbrum, S.
    Brance, M. L.
    JOURNAL OF OSTEOPOROSIS, 2016, 2016
  • [7] EFFECTS OF DENOSUMAB ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN TRANSITIONING FROM RALOXIFENE
    Yeh, K. T.
    Wu, W. -T.
    Thu, C. -H.
    Wang, J. -H.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : 573 - 573
  • [8] DENOSUMAB DECREASES CORTICAL POROSITY IN POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY
    Zebaze, R. M.
    Boyd, S. K.
    Nishiyama, K. K.
    Hanley, D. A.
    Zanchetta, J. R.
    Thomas, T.
    Boutroy, S.
    Bogado, C.
    Austin, M.
    Libanati, C.
    Seeman, E.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : S527 - S527
  • [9] Efficacy and Safety of Denosumab in Osteoporosis or Low Bone Mineral Density Postmenopausal Women
    Chen, Yi
    Zhu, Jun
    Zhou, Yiqin
    Peng, Jinhui
    Wang, Bo
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [10] Denosumab Decreases Cortical Porosity in Postmenopausal Women with Low Bone Mineral Density
    Libanati, C.
    Boyd, S. K.
    Nishiyama, K. K.
    Zebaze, R. M.
    Hanley, D. A.
    Zanchetta, J. R.
    Thomas, Thierry
    Boutroy, S.
    Bogado, C. E.
    Austin, M.
    Seeman, E.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S637 - S638